» Articles » PMID: 38782901

Single-cell and Spatial Transcriptomics Analysis of Non-small Cell Lung Cancer

Abstract

Lung cancer is the second most frequently diagnosed cancer and the leading cause of cancer-related mortality worldwide. Tumour ecosystems feature diverse immune cell types. Myeloid cells, in particular, are prevalent and have a well-established role in promoting the disease. In our study, we profile approximately 900,000 cells from 25 treatment-naive patients with adenocarcinoma and squamous-cell carcinoma by single-cell and spatial transcriptomics. We note an inverse relationship between anti-inflammatory macrophages and NK cells/T cells, and with reduced NK cell cytotoxicity within the tumour. While we observe a similar cell type composition in both adenocarcinoma and squamous-cell carcinoma, we detect significant differences in the co-expression of various immune checkpoint inhibitors. Moreover, we reveal evidence of a transcriptional "reprogramming" of macrophages in tumours, shifting them towards cholesterol export and adopting a foetal-like transcriptional signature which promotes iron efflux. Our multi-omic resource offers a high-resolution molecular map of tumour-associated macrophages, enhancing our understanding of their role within the tumour microenvironment.

Citing Articles

Integrating artificial intelligence in drug discovery and early drug development: a transformative approach.

Ocana A, Pandiella A, Privat C, Bravo I, Luengo-Oroz M, Amir E Biomark Res. 2025; 13(1):45.

PMID: 40087789 DOI: 10.1186/s40364-025-00758-2.


Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications.

Xie X, Liu W, Yuan Z, Chen H, Mao W Mol Cancer. 2025; 24(1):71.

PMID: 40057791 PMC: 11889836. DOI: 10.1186/s12943-025-02269-y.


Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: Current status and future perspectives.

Yoshihara K, Ito K, Kimura T, Yamamoto Y, Urabe F Bladder Cancer. 2025; 11(1):23523735251322017.

PMID: 40034247 PMC: 11864234. DOI: 10.1177/23523735251322017.


Simultaneous immunomodulation and epithelial-to-mesenchymal transition drives lung adenocarcinoma progression.

Kim J, Ravichandran H, Yoffe L, Bhinder B, Finos K, Singh A bioRxiv. 2025; .

PMID: 40027685 PMC: 11870609. DOI: 10.1101/2025.02.19.637138.


Single-Cell RNA Sequencing in Unraveling Acquired Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: New Perspectives.

Peng L, Deng S, Li J, Zhang Y, Zhang L Int J Mol Sci. 2025; 26(4).

PMID: 40003951 PMC: 11855476. DOI: 10.3390/ijms26041483.


References
1.
Sharma A, Seow J, Dutertre C, Pai R, Bleriot C, Mishra A . Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma. Cell. 2020; 183(2):377-394.e21. DOI: 10.1016/j.cell.2020.08.040. View

2.
Sang-Aram C, Browaeys R, Seurinck R, Saeys Y . Spotless, a reproducible pipeline for benchmarking cell type deconvolution in spatial transcriptomics. Elife. 2024; 12. PMC: 11126312. DOI: 10.7554/eLife.88431. View

3.
Lavin Y, Kobayashi S, Leader A, Amir E, Elefant N, Bigenwald C . Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses. Cell. 2017; 169(4):750-765.e17. PMC: 5737939. DOI: 10.1016/j.cell.2017.04.014. View

4.
Leader A, Grout J, Maier B, Nabet B, Park M, Tabachnikova A . Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification. Cancer Cell. 2021; 39(12):1594-1609.e12. PMC: 8728963. DOI: 10.1016/j.ccell.2021.10.009. View

5.
Wu Y, Biswas D, Usaite I, Angelova M, Boeing S, Karasaki T . A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer. Nat Cancer. 2022; 3(6):696-709. PMC: 9236901. DOI: 10.1038/s43018-022-00376-z. View